Ra Capital Management, L.P. Tyra Biosciences, Inc. Transaction History
Ra Capital Management, L.P.
- $5.82 Billion
- Q3 2025
A detailed history of Ra Capital Management, L.P. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 12,198,625 shares of TYRA stock, worth $190 Million. This represents 2.93% of its overall portfolio holdings.
Number of Shares
12,198,625
Previous 12,198,625
-0.0%
Holding current value
$190 Million
Previous $117 Million
46.19%
% of portfolio
2.93%
Previous 2.55%
Shares
6 transactions
Others Institutions Holding TYRA
# of Institutions
116Shares Held
58.4MCall Options Held
23.5KPut Options Held
0-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$63.4 Million95.15% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$63 Million8.64% of portfolio
-
Nextech Invest Ag4.06MShares$63 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.65MShares$56.7 Million2.76% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA3.61MShares$56.1 Million99.51% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $652M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...